Showing 1 - 12 results of 12 for search 'ANDRES F. CARDONA', query time: 0.04s
Refine Results
-
1
-
2
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma by Alejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, Diana Sofía Vargas-Lías, Suraj Samtani, Wendy Muñoz-Montaño, Daniel Motola-Kuba, Luis Corrales-Rodríguez, Claudio Martín, Andrés F. Cardona, Andrés F. Cardona, Andrés F. Cardona, Cittim B. Palomares-Palomares, Oscar Arrieta
Published 2023-12-01
Article -
3
Proposals for the Implementation of a Multidimensional Platform That Allows the Advancement of Oncology Nursing in the Latin American Environment (The INCREASE Proposal) by Milena Parra, Andrea Prada, Alexander Casallas, Liliana Gutiérrez-Babativa, Andrea Jaramillo, Lina Bernal, Claudia Cristina Klumpp, Natalia Sánchez, Nicolle Wagner-Gutíerrez, Andrés F. Cardona
Published 2025-01-01
Article -
4
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cell... by Pedro Barrios-Bernal, Norma Hernandez-Pedro, Mario Orozco-Morales, Rubí Viedma-Rodríguez, José Lucio-Lozada, Federico Avila-Moreno, Andrés F. Cardona, Rafael Rosell, Oscar Arrieta
Published 2022-03-01
Article -
5
Real-World Survival Outcomes in Non–Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country by Juan-Manuel Hernandez-Martinez, Alberto Guijosa, Diana Flores‐Estrada, Graciela Cruz-Rico, Jenny Turcott, Norma Hernández-Pedro, Enrique Caballé‐Perez, Andrés F. Cardona, Oscar Arrieta
Published 2024-12-01
Article -
6
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells by Mikkel G. Terp, Kirstine Jacobsen, Miguel Angel Molina, Niki Karachaliou, Hans C. Beck, Jordi Bertran-Alamillo, Ana Giménez-Capitán, Andrés F. Cardona, Rafael Rosell, Henrik J. Ditzel
Published 2021-07-01
Article -
7
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer by Alejandro Avilés-Salas, Diego A. Díaz-García, Luis Lara-Mejía, Andrés F. Cardona, Mario Orozco-Morales, Rodrigo Catalán, Norma Y. Hernández-Pedro, Eduardo Rios-Garcia, Maritza Ramos-Ramírez, Oscar Arrieta
Published 2022-12-01
Article -
8
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses by Pedro Barrios-Bernal, Zyanya Lucia Zatarain-Barrón, Norma Hernández-Pedro, Mario Orozco-Morales, Alejandra Olivera-Ramírez, Federico Ávila-Moreno, Ana Laura Colín-González, Andrés F. Cardona, Rafael Rosell, Oscar Arrieta
Published 2022-06-01
Article -
9
Case report: Chest radiotherapy-induced vertebral fractures in lung cancer patients: a case series and literature review by Oscar Arrieta, Francisco Lozano-Ruiz, Alberto Guijosa, Pamela Soberanis-Pina, Monika Blake-Cerda, Ana Pamela Gómez-García, Federico Maldonado-Magos, Emilio Conde-Flores, Andrés F. Cardona, Sandra Ileana Pérez Álvarez, Luis Antonio Cabrera-Miranda
Published 2025-02-01
Article -
10
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC by Diego de Miguel‑Perez, Murat Ak, Priyadarshini Mamindla, Alessandro Russo, Serafettin Zenkin, Nursima Ak, Vishal Peddagangireddy, Luis Lara‑Mejia, Muthukumar Gunasekaran, Andres F. Cardona, Aung Naing, Fred R. Hirsch, Oscar Arrieta, Rivka R. Colen, Christian Rolfo
Published 2024-03-01
Article -
11
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors by Carolina Sotelo-Rodríguez, Dora Vallejo-Ardila, Alejandro Ruiz-Patiño, Diego F. Chamorro, July Rodríguez, Darwin A. Moreno-Pérez, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, Leonardo Rojas, Jairo Zuluaga, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Oscar Arrieta, Andrés F. Cardona
Published 2024-01-01
Article -
12
Extracellular vesicles containing SARS‐CoV‐2 proteins are associated with multi‐organ dysfunction and worse outcomes in patients with severe COVID‐19 by Diego deMiguel‐Perez, Marisol Arroyo‐Hernandez, Sabrina La Salvia, Muthukumar Gunasekaran, Edward M. Pickering, Stephanie Avila, Etse Gebru, Eduardo Becerril‐Vargas, Sergio Monraz‐Perez, Kapil Saharia, Alison Grazioli, Michael T. McCurdy, Matthew Frieman, Lisa Miorin, Alessandro Russo, Andrés F. Cardona, Adolfo García‐Sastre, Sunjay Kaushal, Fred R. Hirsch, Djordje Atanackovic, Susmita Sahoo, Oscar Arrieta, Christian Rolfo
Published 2024-11-01
Article